Clinical Kidney Journal

Article	Citations
Prolonged normothermic perfusion: a promising approach to kidney transplantation	229
A puzzling renal Fanconi syndrome	114
Donor-derived membranous nephropathy	100
Circulating miR-129-3p in combination with clinical factors predicts vascular calcification in hemodialysis patients	76
Correction to: Recognition of intraglomerular histological features with deep learning in protocol transplant biopsies and their association with kidney function and prognosis	74
The “Leicester, Leicestershire, and RUtland Chronic Kidney Disease Integrated Care Delivery Project” (LUCID) programme update: the impact on novel kidney therapies	73
Ten tips on management of BK nephropathy in kidney transplant patients	72
Performance of the race-free CKD-EPI creatinine-based eGFR equation in a Danish cohort with measured GFR	65
Meet and greet but avoid the heat: a reflection on the carbon footprint of congresses prompted by ERA2023	64
Causal relationships between immune cell phenotypes and primary glomerular diseases: genetic evidence from bidirectional Mendelian randomization study	63
Differentiating primary and secondary FSGS using non-invasive urine biomarkers	63
Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study	62
Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective	62
Interaction of general obesity and abdominal obesity with frailty in patients with chronic kidney disease: a nationally representative analysis	58
10 tips on performing economic evaluation in kidney disease	57
Novel eGFR equations and cardiovascular outcomes in a multiethnic Asian cohort	56
Recent advances in pathogenetic concepts and disease modeling of IgA nephropathy	55
Erythroferrone is associated with the hepcidin-to-ferritin ratio and cardiovascular mortality in chronic kidney disease	55
Galectin-3 as a prognostic biomarker in haemodialysis patients with preserved or mildly reduced ejection fraction	51
Bilateral nephrectomy in autosomal dominant polycystic kidney disease patients before or after renal transplantation: data from a retrospective cohort study	51
Clonal hematopoiesis of indeterminate potential is associated with increased cardiovascular risk in chronic kidney disease	51
Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function	48
Probability of chronic kidney disease and associated risk factors in Chinese adults: a cross-sectional study of 9 million Chinese adults in the Meinian Onehealth screening survey	47
Informal caregiver burden in dialysis care and how it relates to patients’ health-related quality of life and symptoms	46
Risk factors for acute kidney injury and kidney relapse in patients with lupus podocytopathy	46

Risk factors for steroid-induced osteonecrosis of the femoral head in children with immune kidney disease	45
Non-invasive assessment of IgA nephropathy severity with [18F]AlF-NOTA-FAPI-04 PET/CT imaging	45
Fish oil supplements in patients with chronic kidney disease	43
Biomarkers in clinical epidemiology studies	42
Efficacy and safety of telitacicept, a BLyS/APRIL dual inhibitor, in the treatment of IgA nephropathy: a retrospective case–control study	41
But how green is it actually? Calculating the environmental footprint of kidney care environmental optimizations within haemodialysis	40
Ten tips on how to manage kidney health in migrants and refugees	40
Complement activation in anti-glomerular basement membrane disease before and after treatment with imlifidase	40
Cerebral blood flow following successful living kidney transplantation: the VINTAGE study	39
The use of SGLT2 inhibitors and GLP-1 receptor agonists in older patients: a debate on approaches in CKD and non-CKD populations	38
Obinutuzumab treatment for membranous nephropathy: effectiveness and safety concerns during the COVID-19 pandemic	38
Association between frailty and bone health in early-stage chronic kidney disease: a study from the population-based CARTaGENE cohort	37
Rivaroxaban for the prevention of atherothrombotic events in advanced CKD: are we off TRACK?	37
Use of eHealth and remote patient monitoring: a tool to support home dialysis patients, with an emphasis on peritoneal dialysis	36
Making use of avacopan in clinical practice	36
Machine learning models for predicting acute kidney injury: a systematic review and critical appraisal	36
Clinically meaningful eGFR slope as a surrogate endpoint differs across CKD stages and slope evaluation periods: the CKD-JAC study	35
Safety and efficacy of glucagon-like peptide-1 receptor agonists among kidney transplant recipients: a systematic review and meta-analysis	35
Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus	35
Histological and clinical phenotypes of diabetic kidney disease: a baseline analysis of the HEROIC study	35
Toward acid- and heparin-free dialysis: the regional anticoagulation approach	34
ECOSBot: a multicenter validation pilot study of a generative AI tool for OSCE-based nephrology training	34
The spectrum of diseases, genetic landscape and new mutation sites of hereditary cystic kidney disease	34
Can exercise improve outcomes for frail haemodialysis patients?	34
Complications on the feeding artery after an arterio-venous fistula closure in patients after kidney transplantation – a national cohort study	33
The effect of sevelamer on serum calcification propensity in patients with chronic kidney disease: the results of a multicentre, double-blind, placebo-controlled, randomized clinical trial	33
International validation of a pre-transplant risk assessment tool for graft survival in pediatric kidney transplant recipients	32
Association between beta-blocker utilization and heart failure mortality in the peritoneal dialysis population: a cohort study	32
Cerebral white matter injury in haemodialysis patients: a cross-sectional tract-based spatial statistics and fixel-based analysis	32
Introduction to new CKJ section: In Context – in collaboration with YNP	31
Acute kidney injury due to inhalation of metal fumes	31
Rituximab-based therapy in infection-associated severe crescentic proliferative glomerulonephritis with monoclonal immunoglobulin deposition	31
Self-limited, sodium-dependent osmotic diuresis causes polyuria after living donor kidney transplantation	31
Coordinating efforts to optimize next-generation kidney replacement therapies: the European Kidney Health Alliance Work Group ‘Breakthrough Innovation’	30
Glucose monitoring during hemodiafiltration: a comparison of continuous, capillary, and dialysis-line measurements	29
Visit-to-visit variability in blood pressure and kidney disease progression in IgA nephropathy	29
Efficacy and safety of belimumab in refractory and newly diagnosed active lupus nephritis patients: a real-world observational study	29
Strategies to prevent SARS-CoV-2 transmission in hemodialysis centres across Europe—lessons for the future	29
Comparison of safety and outcomes related to remdesivir treatment among dialysis patients hospitalized with COVID-19	29
Ultrafiltration rate and mortality in patients undergoing extended-hours haemodialysis	28
Urinary peptide signature distinguishes autosomal recessive polycystic kidney disease from other causes of chronic kidney disease	28
Glycaemic control and complications in haemodialysis patients: the TURK-HEMODIAB Study	28
Denosumab-induced hypocalcemia in patients treated with dialysis: an avoidable complication?	27
Troponin I is an independent predictor of cardiovascular events and mortality in haemodialysis patients	27
Kidney Donor Profile Index and allograft outcomes: interactive effects of estimated post-transplant survival score and ischaemic time	27
Genetic and clinical characterization of familial renal glucosuria	27
Clinical outcomes of glucagon-like peptide-1 receptor agonist therapy in kidney transplant recipients: a systematic review and meta-analysis	26
Cardiometabolic protein expression levels and pathways associated with kidney function decline in older European adults with advanced kidney disease	26
Elevated RHAMM as a biomarker for predicting diabetic kidney disease in patients with type 2 diabetes	26
Health-related quality of life in people with autosomal dominant polycystic kidney disease: a systematic review	26

The integrated care model: facilitating initiation of or transition to home dialysis	25
The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease	25
Multiomic profiling of new-onset kidney function decline: insights from the STANISLAS study cohort with a 20-year follow-up	25
Kidney hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in diabetes: physiology and clinical implications	25
Effect of renal denervation on glucose metabolism in hypertensive patients with and without chronic kidney disease	25
Lower serum magnesium levels are associated with a higher risk of fractures and vascular calcifications in hemodialysis patients	24
Renal function is highly associated with podiatric risk in diabetic patients	24
The Many Faces of NELL1 MN	24
The burden of hyperkalaemia in chronic kidney disease: a systematic literature review	24
Fibrillary glomerulonephritis: an observational study of clinical-pathological features and outcomes in patients from a multi-institutional cohort	23
Dapagliflozin in lupus nephritis: renal and hematologic outcomes from a randomized controlled trial	23
Chronic Kidney Disease Outcomes in Patients Treated with Immune Checkpoint Inhibitors	23
The role of low health literacy in shared treatment decision-making in patients with kidney failure	23
Effects of anti-inflammatory agents on clinical outcomes in people with chronic kidney disease: a systematic review and meta-analysis of randomized control trials	23
Should we enlarge the indication for kidney biopsy in patients with diabetes? The pro part	23
Epidemiological risk factors for acute kidney injury outcomes in hospitalized adult patients: a multicenter cohort study	23
Understanding and targeting senescence in kidney disease	22
Short versus long corticosteroid therapy for immune checkpoint inhibitors–induced acute tubulointerstitial nephritis	22
Hemodiafiltration beyond the CONVINCE trial	22
Addressing cognitive impairment in peritoneal dialysis: a systematic review and meta-analysis of prevalence, risk factors, and outcomes	22
A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients	21
Aldosterone synthase inhibition for treatment of people with chronic kidney disease	21
RNA therapeutics in kidney diseases: prospects and current status	21
Association between cause of kidney failure and fracture incidence in a national US dialysis population cohort study	21
A 20-year follow-up study of identical twin sisters with immunoglobulin A nephropathy	21
Genetic testing in focal segmental glomerulosclerosis: in whom and when?	21
Induction therapy for class I/II lupus nephritis with glucocorticoid monotherapy associates with higher relapse and poorer kidney outcomes	21
Estimating 24-hour urine phosphate excretion from spot urine	21
Predicting prognosis in ANCA-associated vasculitis with kidney involvement	20
Mucosal-associated invariant T cells and the gut–kidney axis: a review	20
Correction to: Decongestion in patients with advanced chronic kidney disease coexisting with heart failure	20
Humoral and cellular immunogenicity of a fourth dose BNT162b2 in children with chronic kidney diseases	20
Sodium zirconium cyclosilicate post hospital discharge to prevent hyperkalaemia: phase 4, randomized CONTINUITY trial	20
Frailty assessment in kidney transplantation: insights from a European survey	20
Integrating multiple kidney function markers to predict all-cause and cardiovascular disease mortality: prospective analysis of 366 758 UK Biobank participants	20
Partnering with patients and caregivers to enrich research and care in kidney disease: values and strategies	20
The impacts of hypoxia-inducible factor stabilizers on laboratory parameters and clinical outcomes in chronic kidney disease patients with renal anemia: a systematic review and meta-analysis	20
Potassium management and heart failure: a nephrologist's perspective	20
What to do with key cardiovascular drugs when kidney function worsens?	20
Novel NUP160 mutations related to simultaneous congenital nephropathy and ovarian insufficiency	20
Urgent initiation of hemodialysis versus peritoneal dialysis in severe hyperkalemia: a prospective study	19
Valvular heart disease in patients on kidney replacement therapy: “opening Pandora's box”	19
Implementing a model of integrated CKD management between primary and secondary care	19
Sodium glucose co-transporter 2 inhibitors in the treatment of glomerular diseases: a CKJ controversy	19
Remote management of anaemia in patients with end-stage kidney disease using a wearable, non-invasive sensor	19
Association of deprivation and its individual domains on outcomes in people with chronic kidney disease	19
Fatigue across different chronic kidney disease populations: experiences and needs of patients	19
Hereditary kidney tumor syndromes: structured evaluation of a questionnaire-based approach	19
Personalizing electrolytes in the dialysis prescription: what, why and how?	19
Dapagliflozin in chronic kidney disease: cost-effectiveness beyond the DAPA-CKD trial	19
Designing qualitative research with value in the clinical and epidemiological context: what, why and how	18
Endothelin receptor antagonists in diabetic and non-diabetic chronic kidney disease	18
From electronic health records to clinical management systems: how the digital transformation can support healthcare services	18
Liver safety of tolvaptan in patients with autosomal dominant polycystic kidney disease: interim data from a post-authorization safety study	18
Decoy receptors as biomarkers for exploring aetiology and designing new therapies	18
Collagen type III formation but not degradation is associated with risk of kidney disease progression and mortality after acute kidney injury	18
Finding the sweet spot in green nephrology: the intersection of environmental sustainability and excellence in patient care	18
Prevalence, awareness, treatment, and control of hypertension in community-dwelling older adults with chronic kidney disease: the Irish longitudinal study on ageing	18
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association	18
Integrative analysis of the association between circadian rhythm and lupus nephritis	18
Automating kidney transplant rejection diagnosis: a simple solution for a complex problem?	18
Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studies	18
Treatment response to daratumumab in antibody-mediated kidney allograft rejection (ABMR): evidence from serial protocol biopsies	18
Thrombotic microangiopathy after kidney transplantation: diagnosis and management strategies	18
Current practices in prevention, screening, and treatment of diabetes in kidney transplant recipients: European survey highlights from the ERA DESCARTES Working Group	18
Gamified renal point-of-care ultrasound to promote recruitment and anatomical competence in nephrology	18
Differences in association between hypoalbuminaemia and mortality among younger versus older patients on haemodialysis	17
Leukopenia in autosomal dominant polycystic kidney disease: a single-center cohort of kidney transplant candidates with post-transplantation follow-up	17
Performance of creatinine and cystatin C-based equations for estimating high levels of glomerular filtration rate in Congolese adults with sickle cell disease	17
Correction to: Clinical implications of mineralocorticoid receptor overactivation	17
Long-term effect of increasing water intake on repeated self-assessed health-related quality of life (HRQoL) in autosomal dominant polycystic kidney disease	17
Preserving residual kidney function in peritoneal dialysis: from conventional approaches to contemporary practice	17
The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment	17
Prospective evaluation of CAR-T cell therapy-related proteinuria and kidney dysfunction	17
Renal involvement is frequent in adults with primary mitochondrial disorders: an observational study	17
National Unified Renal Translational Research Enterprise: Idiopathic Nephrotic Syndrome (NURTuRE-INS) study	17
Anticoagulation in patients with end-stage kidney disease and atrial fibrillation: a national population-based study	16
Cancer risks in people on dialysis and kidney transplant recipients: a Catalan cohort study, 2003–21	16
Anti-phospholipid antibodies nephropathy is associated with an increased risk of kidney failure: a systematic literature review and meta-analysis	16
Telitacicept versus mycophenolate mofetil in IgA nephropathy: a real-world comparative study of efficacy, renal outcomes and safety	16

Rituximab as a first-line therapy in children with new-onset idiopathic nephrotic syndrome	16
Three decades of CKD due to diabetes mellitus type 2 in China, with projections of disease burden from 2022 to 2036: a systematic analysis for the Global Burden of Disease Study 2021	16
Novel equations for estimating intraperitoneal pressure among peritoneal dialysis patients	16
Executive summary of the European consensus report on the diagnosis and treatment of monoclonal gammopathy of renal significance	16
New and old GFR equations: a European perspective	16
Machine learning models for mortality prediction in critically ill patients with acute pancreatitis–associated acute kidney injury	16
Dynamic prediction of kidney allograft and patient survival using post-transplant estimated glomerular filtration rate trajectory	16
Evolving kidney disease phenotypes in type 2 diabetes: declining albuminuria and increasing isolated low eGFR	16
Subcutaneous ofatumumab for remission maintenance in pediatric idiopathic nephrotic syndrome: a case series	16
Evolving practices in pre-transplant cardiovascular screening: moving toward personalized assessments	16
Urine albumin-to-creatinine ratio as a predictor of kidney function decline in Alport syndrome	15
Urinary soluble PD-1 as a biomarker of checkpoint inhibitor-induced acute tubulointerstitial nephritis	15
Longitudinal serum bicarbonate and mortality risk in older patients with advanced chronic kidney disease: analyses from the EQUAL cohort	15
Sodium–glucose co-transporter inhibitors, refractory hypomagnesaemia and recurrent genital mycotic infections	15
Cardiovascular risk prediction in hemodialysis patients using the triglyceride-glucose index: a multicenter prospective cohort study	15
Epigenetic mechanisms of salt-sensitive hypertension	15
Personalized peritoneal dialysis prescription—beyond clinical or analytical values	15
Association of albuminuria with incident atrial fibrillation in healthy older adults	15
Management of hypertension in patients with cancer: challenges and considerations	15
A decade of complement inhibition in post-transplant atypical HUS: outcomes with eculizumab and ravulizumab	15
Trunk muscle quality and quantity are associated with renal volume in nondiabetic people	15
Immobilization-associated hypercalcaemia in patients with malignancy in the hospital setting	15
Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab	15
COVID-19 among kidney transplant recipients: evaluating risk factors during the initial phase of the pandemic	15
Synergistic effect of teclistamab with PD-1 inhibition: a case of acute interstitial nephritis with dual immunotherapy	15
Considering the utility of urinary amino acids for early identification of non-diabetic chronic kidney disease	15
Nafamostat mesylate has advantages as an anticoagulant for patients undergoing maintenance hemodialysis with conjunctival bleeding	15
Association of tryptophan metabolites with cognitive impairment in chronic kidney disease	15
The role of blood purification therapies in the treatment of chronic kidney disease–associated pruritus: a systematic review	15
Which equation and which biomarker should be used in the Kidney Failure Risk Equation? A comparative analysis in the CKD-REIN cohort	15
Preferences for healthcare decisional control in older people with chronic kidney disease in the UK indicate strong inclinations towards active and collaborative approaches	15
Hyponatremia and the risk of sepsis in the setting of chronic kidney disease not on dialysis	15
Time-averaged concentration estimation of uraemic toxins with different removal kinetics: a novel approach based on intradialytic spent dialysate measurements	15
Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort	15
Correction to: Moving on obesity treatment in CKD: inertia is unjustified	15
Multiparametric MRI: can we assess renal function differently?	15
Performance of an interstitial glucose monitoring device in patients with type 1 diabetes during haemodialysis	14
The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1–3a CKD patients	14
Risk factors for major bleeding in patients with atrial fibrillation and CKD G3–G5D on oral anticoagulants	14
Incremental versus conventional haemodialysis in end-stage kidney disease: a systematic review and meta-analysis	14
Association between nephrolithiasis and kidney disease progression in patients with autosomal dominant polycystic kidney disease: a prospective cohort study	14
Social deprivation as a key driver of spatial disparities in end-stage kidney disease incidence	14
Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor–associated membranous nephropathy	14
Association between serum short-chain fatty acid levels and the risk of all-cause and cardiovascular disease mortality in Chinese patients undergoing maintenance hemodialysis: a retrospective cohort s	14
Twenty-four-hour proteinuria levels are associated with adverse pregnancy outcomes among women with CKD	14
The elevation of the anion gap in steady state chronic kidney disease may be less prominent than generally accepted	14
New trials in resistant hypertension: mixed blessing stories	14
Malignancies and glomerulonephritis: when to suspect and when to screen?	14
2025 Update on resistant hypertension in CKD: where do we stand and where do we go?	14
Mortality associated with the COVID-19 pandemic in the Swiss dialysis population beyond SARS-CoV-2 infection	14
Citrullinated histone H3 identifies neutrophil extracellular trap formation and correlates with renal disease activity in ANCA-associated vasculitis	14
Anti-nephrin antibody: a potential biomarker of minimal change disease	14
Ten tips to preserve and reuse water in nephrology	13
Are we ready for an adipocentric approach in people living with type 2 diabetes and chronic kidney disease?	13
Correction to: Spatially resolved transcriptomic profiling for glomerular and tubulointerstitial gene expression in C3 glomerulopathy	13
Asymmetric dimethylarginine and citrulline are risk factors for cardiovascular disease independently of both estimated and measured GFR	13
Hypomagnesemia in patients on oral EGFR tyrosine kinase inhibitors: renal magnesium wasting or concurrent confounders?	13
Incidence and prognosis of acute kidney injury versus acute kidney disease among 71 041 inpatients	13
Dialysis modality and survival in octogenarians: real-world population-based cohort study	13
The impact of intradialytic cycling on temporal changes in muscle sodium during hemodialysis	13
Prospective study of the effect of rituximab on kidney function in membranous nephropathy	13
Uraemic burden index: a novel predictor of pre-emptive kidney transplant outcome	13
The ERA Registry Annual Report 2023: epidemiology of kidney replacement therapy in Europe, with a focus on age comparisons	13
Intra-individual fluctuations in alkaline phosphatase predict mortality and CKD progression: insights from a large CKD cohort	13
Real-world usage of Chronic Kidney Disease – Mineral Bone Disorder (CKD–MBD) biomarkers in nephrology practices	13
A review of supportive care for older people with advanced chronic kidney disease	13
Urinary microvesicles: a window into the kidney	13
Lung ultrasonography performed by nephrologist: COVID-19 as an opportunity to reveal ultrasound's full potential and usefulness in the dialysis room	13
Ten tips to teach learners to love nephrology (and recruit the next generation)	13
Prophylactic proton pump inhibitor usage and new-onset acute kidney injury in critically ill patients: a retrospective analysis	13
Mechanisms and treatment of obesity-related hypertension—Part 2: Treatments	13
Congestion as a crucial factor determining albuminuria in patients with cardiorenal disease	13
Chronic kidney disease duration and suicide risk among maintenance hemodialysis patients in China	12
Bone mineral density after exercise training in patients with chronic kidney disease stages 3 to 5: a sub-study of RENEXC—a randomized controlled trial	12
Safety and clinical impact of SGLT2 inhibitor in patients undergoing peritoneal dialysis: a target-trial emulation study	12
An update on absolute and relative indications for dialysis treatment modalities	12
Circulating metabolites associated with kidney function decline and incident CKD: a multi-platform population-based study	12
Glucagon-like peptide-1 receptor agonists and cardiovascular outcomes in dialysis patients with type 2 diabetes: a real-world propensity score-matched study	12
Activation of the inflammasome and pyroptosis cascade in podocytes of patients with minimal change disease	12
Quantifying the potential contribution of drugs to the occurrence of acute kidney injury in patients with chronic kidney disease	12
Cystatin C–based estimated glomerular filtration rate and risk of stroke in the general population: a prospective cohort study	12
Trajectories of urea‑to‑creatinine ratio and risk of clinical outcomes in survivors of acute kidney disease: a population-based study	12
Prophylactic ultra-low dose rituximab to maintain remission in relapsing adult minimal change disease	12
Hyperkalemia risk with finerenone in diabetic kidney disease: a real-world analysis from the FINE-TURK cohort	12
Kidney Failure Risk Equation performance according to the etiology of chronic kidney disease in the CKD-CAREMEAU cohort	12
Disturbance in the potential cardiovascular–bone–skeletal muscle axis and morbidity and mortality in patients undergoing haemodialysis: the Q-Cohort Study	12
Albuminuria after induction treatment and kidney prognosis in ANCA-associated glomerulonephritis	12
Correction to: Using artificial intelligence to predict mortality in AKI patients: a systematic review/meta-analysis	12
International variations in chronic kidney disease patients’ pain experience and its management	12
The long-term benefits of early intensive therapy in chronic diseases—the legacy effect	12
ERA Registry Figure of the month Expected remaining years of life for dialysis and kidney transplant patients	12
Similar predictive performance and clinical utility of the Kidney Failure Risk Equation using EKFC or CKD-EPI estimated glomerular filtration rate	12
Associations between iron markers with hemoglobin and outcomes in peritoneal dialysis patients: results from the PDTAP study	12
Ionized and total magnesium levels in patients with chronic kidney disease: associated factors and outcomes	12
Efficacy and safety of finerenone in IgA nephropathy: an observational multicentre study	12